As of November 15, 2026, Integra LifeSciences Holdings Corp is a publicly traded company (Nasdaq: IART); its largest reported holder is BlackRock, with 13.2% on Schedule 13G/A of July 17, 2025, then Rubric Capital Management LP (9.46%). The largest insider holding is Stuart Essig, a director, with 1,785,271 shares (2.3% of shares outstanding), per Form 4 of August 18, 2025 (Schedule 13G/A, July 17, 2025).
Is this your company?
About to sign with, pay or invest in Integra LifeSciences Holdings Corp? See the free Snapshot first.
Free to see. No signup.
Is Integra LifeSciences Holdings Corp a real, registered company?
- Integra LifeSciences Holdings Corp files with the SEC under CIK 917520 (its SEC filings).
- Its shares are listed under the ticker IART on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Princeton, New Jersey, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Integra LifeSciences Holdings Corp in our court records and SEC 8-K records (as of 2026-11-15).
- Leadership changes: the latest reported is Michael McBreen, Chief Commercial Officer (Form 8-K filed 2026-05-05). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Invesco (filed 2026-11-10).
Who are Integra LifeSciences Holdings Corp's owners and officers?
Integra LifeSciences Holdings Corp: incorporated in Delaware; business address in Princeton, New Jersey; industry Surgical & Medical Instruments & Apparatus (Schedule 13G, 2026-11-10).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-11-10 | Invesco LTD. | 5.4% |
| Schedule 13G/A, 2026-08-13 | Paradigm Capital Management Inc/Ny | — |
| Schedule 13G, 2026-07-31 | Vanguard Portfolio Management | 5.02% |
| Schedule 13G, 2026-05-15 | Paradigm Capital Management Inc/Ny | 5.2% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-02-17 | Fuller & Thaler Asset Management, Inc. | 4.67% |
| Schedule 13G/A, 2025-11-06 | Invesco LTD. | 4.5% |
| Schedule 13G/A, 2025-08-05 | Morgan Stanley | 4.3% |
| Schedule 13G/A, 2025-07-17 | Blackrock, Inc. | 13.2% |
| Schedule 13G/A, 2025-07-09 | Rubric Capital Management LP | 9.46% |
Questions about who owns Integra LifeSciences Holdings Corp
Who owns Integra LifeSciences Holdings Corp?
On this page, 4 holders' latest ownership filings report 5% or more of Integra LifeSciences Holdings Corp: Blackrock, Inc. (13.2%, Schedule 13G/A, filed 2025-07-17), Rubric Capital Management LP (9.46%, Schedule 13G/A, filed 2025-07-09), Invesco LTD. (5.4%, Schedule 13G, filed 2026-11-10) and Vanguard Portfolio Management (5.02%, Schedule 13G, filed 2026-07-31).
Who are the largest shareholders of Integra LifeSciences Holdings Corp?
By the share each holder's latest filing reports, the largest holders of Integra LifeSciences Holdings Corp on this page are Blackrock, Inc. (13.2%), Rubric Capital Management LP (9.46%) and Invesco LTD. (5.4%).
When did Blackrock, Inc. buy into Integra LifeSciences Holdings Corp?
The filings give report dates, not purchase dates. The earliest filing from Blackrock, Inc. on this page is the Schedule 13G/A, filed 2025-07-17, reporting 13.2%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 10 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Integra LifeSciences Holdings Corp?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Integra LifeSciences Holdings Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Integra LifeSciences Holdings Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-05-05 | Michael McBreen | Chief Commercial Officer | appointed |
Which insiders own Integra LifeSciences Holdings Corp shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director: 1,785,271 shares (2.3% of shares outstanding), 1,152,236 held directly and 633,035 indirectly (Form 4, 2025-08-18).
- , a director: 187,541 shares (0.24% of shares outstanding), 151,191 held directly and 36,350 indirectly (Form 4, 2026-05-11).
- , a director: 90,034 shares (0.12% of shares outstanding) (Form 4, 2025-05-13).
- , a director: 88,254 shares (0.11% of shares outstanding) (Form 4, 2026-05-11).
- , the president and executive vice president: 66,387 shares (0.09% of shares outstanding) (Form 4, 2026-03-12).
Shares outstanding: 77,800,976 as of 2026-10-22, from the company's latest SEC cover page.
How much has Integra LifeSciences Holdings Corp raised?
No fundraising or offering filing from Integra LifeSciences Holdings Corp is on file with us.
Keep reading
More on Integra LifeSciences Holdings Corp and the records around it.
Integra LifeSciences Holdings Corp elsewhere on the record
- Leadership changes May 2026
Companies that share a holder
- PARADIGM CAPITAL MANAGEMENT INC/NY also filed stake reports on 7 other companies: ACCENDRA HEALTH INC/VA/ (Nov 2026), BUILD-A-BEAR WORKSHOP INC (Aug 2026), NN INC (Feb 2026)
- Rubric Capital Management LP also filed stake reports on 32 other companies: ARDELYX, INC. (Aug 2026), Enovis Corporation (Aug 2026), MeiraGTx Holdings plc (Aug 2026)
- Fuller & Thaler Asset Management, Inc. also filed stake reports on 35 other companies: COLLEGIUM PHARMACEUTICAL, INC (Aug 2026), Graphic Packaging Holding Co (Aug 2026), Primoris Services Corp (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/integra-lifesciences